Piermont Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-24,300
| Closed | -$2.75M | – | 207 |
|
|
2018
Q2 | $2.75M | Buy |
24,300
+18,230
| +300% | +$2.06M | 0.84% | 40 |
|
|
2018
Q1 | $682K | Sell |
6,070
-290
| -5% | -$32.6K | 0.23% | 129 |
|
|
2017
Q4 | $941K | Buy |
6,360
+3,860
| +154% | +$571K | 0.31% | 112 |
|
|
2017
Q3 | $293K | Sell |
2,500
-590
| -19% | -$69.1K | 0.1% | 222 |
|
|
2017
Q2 | $401K | Buy |
+3,090
| New | +$401K | 0.11% | 237 |
|
|
2016
Q2 | – | Sell |
-2,350
| Closed | -$262K | – | 283 |
|
|
2016
Q1 | $262K | Hold |
2,350
| – | – | 0.08% | 214 |
|
|
2015
Q4 | $368K | Hold |
2,350
| – | – | 0.12% | 185 |
|
|
2015
Q3 | $308K | Hold |
2,350
| – | – | 0.1% | 194 |
|
|
2015
Q2 | $409K | Hold |
2,350
| – | – | 0.12% | 184 |
|
|
2015
Q1 | $405K | Buy |
+2,350
| New | +$405K | 0.12% | 184 |
|